Drug safety crackdown revs up.
Ledford
Heidi
H
D001552:Benzazepines / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D011358:Product Surveillance, Postmarketing; D011810:Quinoxalines / Q000009:adverse effects*; D018570:Risk Assessment; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000009:adverse effects; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence*; D000068580:Varenicline; D014754:Violence
D001552:Benzazepines; D011810:Quinoxalines; D045162:Thiazolidinediones; D000077154:Rosiglitazone; D000068580:Varenicline